Seeing Is Believing

Currently out of the existing stock ratings of Joseph Schwartz, 49 are a HOLD (18.7%), 207 are a BUY (79.01%), 6 are a SELL (2.29%).
Analyst Joseph Schwartz, carries an average stock price target met ratio of 59.01% that have a potential upside of 53.34% achieved within 366 days. Previously, Joseph Schwartz worked at LEERINK.
Joseph Schwartz’s has documented 513 price targets and ratings displayed on 49 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on SPRB, Spruce Biosciences at 20-Oct-2025.
Analyst best performing recommendations are on LRMR (LARIMAR THERAPEUTICS).
The best stock recommendation documented was for LRMR (LARIMAR THERAPEUTICS) at 12/1/2015. The price target of $132 was fulfilled within 1 day with a profit of $59.16 (30.95%) receiving and performance score of 309.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$13.75
$14
5 years 26 days ago
(04-Oct-2020)
13/18 (72.22%)
$0.67 (5.12%)
50
Buy
$13.75
$14
5 years 29 days ago
(01-Oct-2020)
5/7 (71.43%)
$0.01 (0.07%)
130
Hold
$10
$-3.75 (-27.27%)
$13
5 years 2 months 13 days ago
(17-Aug-2020)
6/8 (75%)
$-0.63 (-5.93%)
126
Buy
$10
$-3.75 (-27.27%)
$14
5 years 2 months 13 days ago
(17-Aug-2020)
1/5 (20%)
$-0.63 (-5.93%)
6
Hold
5 years 2 months 24 days ago
(06-Aug-2020)
0/3 (0%)
$17.19 (61.81%)
Which stock is Joseph Schwartz is most bullish on?
Which stock is Joseph Schwartz is most reserved on?
What Year was the first public recommendation made by Joseph Schwartz?